Announcements

27 February 2025
Meet Us at the 19th Conference of the International Society of Travel Medicine (CISTM19), 11–15 May 2025, New Orleans, USA


Conference: 19th Conference of the International Society of Travel Medicine (CISTM19)
Organization: International Society of Travel Medicine
Date: 11–15 May 2025
Place: New Orleans, Louisiana, USA
Booth ID: #19

A number of MDPI journals will be attending CISTM19 as exhibitors. This meeting will be held in New Orleans, USA, from 11 to 15 May 2025.

CISTM19 is the premier gathering of approximately 1,100+ travel medicine specialists and practitioners to learn about the latest developments and new and innovative technologies, products, and services, as well as to contribute to the evolving field of travel medicine.

The following MDPI journals will be represented:

  • TropicalMed;
  • COVID;
  • Diseases;
  • Antibiotics;
  • Parasitologia;
  • Life;
  • Viruses;
  • Healthcare;
  • Vaccines;
  • Women;
  • Children;
  • Infectious Disease Reports;
  • Microorganisms;
  • Epidemiologia.

If you will be attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference, please visit the following website: https://www.istm.org/event/cistm19/.

27 February 2025
More than 300 MDPI Journals Indexed in Web of Science

MDPI is pleased to share a significant milestone in its mission to advance scholarly research and promote the dissemination of knowledge—300+ MDPI journals are now indexed in Web of Science (WoS). This milestone highlights the global recognition, interdisciplinary impact and enhanced visibility of our journals. It also reflects our adherence to rigorous editorial standards, scientific integrity, and our mission to foster open scientific exchange in all forms, across all disciplines. 

To explore the full list of our journals indexed in WoS, please visit https://www.mdpi.com/about/journals/wos. Beyond expanding the coverage of our publications in the leading academic databases, we are dedicated to ensuring that our journals are included in as many scope-specific databases as possible. This increases the visibility of our authors’ work and extends the reach of their significant data. 

This milestone would not have been possible without the efforts and expertise of our academic editors, reviewers and authors. Their commitment and collaboration have been instrumental in creating an inclusive, accessible, and impactful publishing platform. We also extend our gratitude to the global research community for their trust as we continue to break new ground in academic publishing. This milestone is not just a celebration of MDPI’s progress but also recognition of the collective strides made by researchers worldwide. 

As we celebrate this remarkable accomplishment, MDPI remains steadfast in its commitment to open access publishing and ensuring that high-quality research reaches and inspires a global audience.

24 February 2025
Meet Us at the Anatomy–Physiology–Pharmacology Week in 2025, 17–19 March 2025, Osaka, Japan


Conference:
Anatomy–Physiology–Pharmacology Week in 2025
Date: 17–19 March 2025
Location: Osaka, Japan

MDPI will be attending APPW 2025 as an exhibitor. We welcome researchers from different backgrounds to visit and share their latest ideas with us.

The Japanese Association of Anatomists, the Physiological Society of Japan, and the Japanese Pharmacological Society are the oldest academic organizations in basic medicine representing Japan, and each has a long history of academic activity. The theme of this joint conference of the three academic societies (English name: Anatomy–Physiology–Pharmacology Week 2025, abbreviated as APPW 2025) is “Toward the Future of Concert—Exploring, Elucidating, and Protecting Life”.

The following MDPI journals will be represented at the conference:

If you are planning to attend this conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.aeplan.jp/appw2025/.

20 February 2025
Prof. Dr. Omar Cauli Appointed Editor-in-Chief of Diseases


We are pleased to announce that Prof. Dr. Omar Cauli has been appointed as the Editor-in-Chief of Diseases (ISSN: 2079-9721).

Prof. Dr. Omar Cauli is a professor of pathophysiology at the Department of Nursing at the University of Valencia, Valencia, Spain. He graduated with a degree in pharmacy at the University of Cagliari (Italy) and a degree in medicine at the University of Valencia (Spain). He also has a Ph.D. in neuroscience with a specialization in pharmacology from the University of Valencia. For the past 25 years, Prof. Dr. Omar Cauli has specialized in the fields of neuro-psychiatric diseases and geriatric medicine. He joined the journal Diseases as the Section Editor-in-Chief for the Section “Neuro-psychiatric Disorders” in 2018. He also serves as a Guest Editor and Topic Editor and has led several Special Issues and Topic Collections for Diseases and other MDPI journals.

Prof. Dr. Omar Cauli is also the Chair of the 1st International Online Conference on Diseases, which will be held from 9 to 11 September 2025. For more information, you may refer to https://sciforum.net/event/IOCD2025?section=#instructions.

The following is a short Q&A with Prof. Dr. Omar Cauli, who shared his vision for the journal and his views on the research area:

1. What about the journal appealed to you and made you want to take on the role as its Editor-in-Chief?

Diseases provides an invaluable platform for high-quality innovative scholarship dealing with diseases, ranging from the molecular to the clinical points of view, thanks to the efforts of the previous Editor-in-Chief, Prof. Dr. Maurizio Battino. I have had a pleasant experience with the journal as the Section Editor-in-Chief for the Section “Neuro-psychiatric Disorders” since 2018, during which I have edited five Special Issues for the journal while serving on the Editorial Board of Diseases. I have been very grateful for these opportunities.

2. What is your vision for the journal Diseases?

While keeping up the high standards for scholarship that Diseases has established, I do hope to expand the journal’s scope in certain fields. I have added two new Subject Sections “Endocrine and Metabolic Diseases” and “Autoimmune/Inflammatory Diseases”, with the goal of including a variety of approaches derived from the study of these fields. I see the need to bring in several Associate Editors to support this expansion.

3. What does the future of this field of research look like?

Due to the continuous progress of science and medicine, it is evident that the field of diseases, from the molecular to the clinical perspectives, will continue to grow and evolve.  The scientific evidence so far suggests that from the clinical point of view, inter- and multidisciplinary approaches are crucial for disease management. In addition, a personalized approach to individuals and patients with certain types of diseases will be the future of the treatment and care of people with health problems. I would like the journal to present papers that are based on the latest advances which are rooted in new molecular discoveries regarding each disease and the multidisciplinary and interdisciplinary approaches to disease management, especially in the context of chronicity.

4. What do you think of the development of open access research in the publishing field?

Open access publication of scientific results creates a level playing field for all researchers worldwide, regardless of their location, status, or affiliation. It can only be a good thing. It removes the limitations and biases of intellectual development from parts of academia and allows everyone to keep up with scientific advances, regardless of their ability to pay to learn. It may be a difficult balance from the publishers’ point of view, but to me, it is the right direction.

We warmly welcome Prof. Dr. Omar Cauli as our Editor-in-Chief and look forward to his valuable input for the continued success of Diseases. Further details regarding the journal and the latest news can be found at the following link: https://www.mdpi.com/journal/diseases.

17 February 2025
MDPI Celebrates Excellence in Medical Research with Early Career Researcher Awards


MDPI, a pioneer in scholarly open access publishing, and the Lee Kong Chian School of Medicine (LKCMedicine), Singapore, proudly announce the successful conclusion of the first edition the MDPI Early Career Researcher Awards. The awards, which recognize outstanding contributions to medical and biomedical research, were presented to six exceptional researchers during an awards ceremony held at LKCMedicine HQ Building on 28 November 2024.

Honoring Excellence in Research

The awards recognize exceptional postdoctoral researchers and Ph.D. students who have demonstrated outstanding originality, innovation, and impact in their respective fields. We are honored to announce the winners of the 2024 edition:

Early Career Researcher (Postdoc) Award:

  • Dr. Theresia Handayani Mina, “Adiposity and Metabolic Health in Asian Populations: An Epidemiological Study Using Dual-Energy X-Ray Absorptiometry in Singapore”;
  • Dr. Erfan Rezvani Ghomi, “Wound Healing Improvement by Novel Aligned Antimicrobial Nanofibrous 3D Scaffolds”;
  • Dr. Yadollah Ranjbar Slamloo, “Functional Alterations of The Prefrontal Circuit Underlying Cognitive Aging in Mice”.

Early Career Researcher (Ph.D.) Award:

  • Pritisha Rozario, “Mechanistic Basis for Potassium Efflux-Driven Activation of the Human NLRP1 Inflammasome”;
  • Michelle Law Cheok Yien, “Chikungunya Virus Nonstructural Protein 1 is a Versatile RNA Capping and Decapping Enzyme”;
  • Yin Ruoyu, “The Use of Digital Mental Health and Wellbeing Tools in Older Adults: A Mixed Method Study”.

Our collaboration highlights a shared commitment to recognizing exceptional talent and research within the academic community, addressing today’s healthcare challenges, and inspiring continued innovation.

Looking Ahead to 2025

Building on the success of the first edition, MDPI and LKCMedicine are excited to announce that the 2025 MDPI Early Researcher Awards will continue to celebrate excellence and innovation in medical research. The next edition promises to expand its scope, introducing new categories and providing even greater recognition for impactful research.

Further details on the 2025 awards, including nomination criteria and timelines, will be shared in the coming months. We remain committed to fostering a culture of research excellence and collaboration within the global scientific community.

5 February 2025
MDPI INSIGHTS: The CEO's Letter #20 - Beijing, Singapore, Bangkok, JAMS, Jisc

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

2024 Annual Meeting – Beijing (15 January 2025)

You haven’t truly experienced a New Year’s celebration until you’ve attended one of MDPI’s Chinese Annual Meeting festivities. This year I visited our annual meeting in Beijing, held on the 15th of January.

Imagine this: stepping into a banquet hall filled with 140 tables and about 1,400 colleagues from our Beijing offices, all gathered to share in a six-hour event. The agenda included year-end speeches and presentations, a variety of performances by our colleagues, a selection of awards honouring local employees for their work, group photos for the memories, and a dinner.

This may have been one of the largest events I have attended. For those unaccustomed to such an event, it might seem overwhelming, but it was quite the opposite. The atmosphere was one of celebration as everyone came together to support their peers and celebrate the achievements of 2024.

I was honoured to deliver the opening speech and a presentation highlighting our growth and investment in MDPI’s most valuable asset: our people.

“Our editorial teams represent MDPI at its finest”

I want to give special recognition to the editorial department, across all of our offices, which forms the heart of our business. These teams are the frontline communicators with our authors, reviewers, and guest editors, creating a smooth experience of processing our manuscripts. Their professionalism and kindness are often highlighted as key drivers of satisfaction with MDPI. For this, I extend my deepest gratitude to all our editorial staff, across every office. They truly represent MDPI at its finest.

Beijing is home to two of our offices, with just over 800 employees in Tongzhou and over 600 in Haidian. Thank you to our administrative teams and everyone involved in organizing these New Year’s celebrations across all offices. These events provide a moment to reflect on our shared accomplishments and appreciate the positive impact each of you has on our culture.

MDPI Offices in China

While the history of MDPI begins in Basel, Switzerland, the story of MDPI is very much rooted in China. Below is a list of MDPI’s current offices in China and their respective dates of inauguration:

  • 2008: Beijing (Tongzhou, Haidian)
  • 2013: Wuhan (Hankou, Guanggu)
  • 2019: Tianjin
  • 2021: Dalian
  • 2021: Nanjing

To date, over 381,000 MDPI research articles have been published by authors affiliated with Chinese institutions, making China our largest market. This is reflected not only in the volume of publications but also in the scale of our workforce supporting local operations and contributing to global success.

While no new offices in China were launched between 2022 and 2024 due to the pandemic and strategic planning, we remain committed to future growth here. Our plans include expanding operations as we continue to build our global workforce.

We look forward to a year filled with continued collaboration, growth, and shared success.

“We remain committed to future growth in China”

Impactful Research

MDPI and Jisc Consortium Extend Open Access Agreement for 2025

I’m pleased to share that MDPI has extended its agreement with the Jisc consortium in the UK for 2025. This renewal strengthens our partnership with UK institutions and reaffirms our shared commitment to advancing open access publishing.

Jisc is the UK’s not-for-profit digital, data, and technology agency supporting tertiary education, research, and innovation. Through initiatives such as our agreement, Jisc helps institutions access essential digital resources and infrastructure to support researchers. Currently, 62 UK institutions are part of our Institutional Open Access Program (IOAP) through this partnership.

Authors from participating institutions benefit from discounts on article processing charges (APCs), with even greater support for institutions that centrally fund APCs. This helps researchers focus on their work while simplifying the publishing process.

A full list of participating institutions can be found here.

As Becky Castellon, our Institutional Partnerships Manager, puts it: “Extending our agreement with Jisc is a reward for the strong partnership we’ve built with research institutions throughout the UK.”

At MDPI, we are dedicated to making research more accessible while reducing administrative burdens for institutions and authors. Open access publishing is at the heart of what we do, and we’re proud to expand its reach in the UK and beyond.

Inside MDPI

Visit to MDPI's Singapore office

During my January trip to some of our APAC offices, I also had the pleasure of visiting our Singapore office for the first time. It’s exciting to see how much the team has grown, now numbering over 55 staff members, with more joining us in February.

Welcoming and Supporting New Team Members

“Experienced staff play an important role in mentoring new hires”

I had the opportunity to connect with both experienced colleagues and new team members who are currently embarking on their careers. This visit reminded me of what it was like when I was in their shoes. I encourage all of us to engage new colleagues with empathy, as we have all been in their position. By creating a welcoming and supportive environment, we can help them settle in and learn about the corporate world, MDPI and our mission.

Experienced staff play an important role in mentoring and guiding new hires, most of whom are transitioning from academia to their first job. I’m especially grateful to colleagues such as Colin Chen, Alicia Ren, Yu Nwe Soe, Colin Wee, Amy Cham and other senior members who have contributed to shaping the culture and work environment in Singapore.

Building MDPI’s Positive Reputation

During my visit, I spoke with the office staff about the importance of their roles in building a positive reputation that helps create trust in MDPI. I shared how every interaction and communication point contributes to the marketing of MDPI and our journals. I also highlighted the career development opportunities available as MDPI continues to grow.

Connecting with the Singapore Marketing Team

I also spent time connecting directly with the Singapore Marketing team, which has quickly grown to 15 young and ambitious members. They are eager to learn and are actively contributing to our journal and corporate marketing activities. I shared insights into our corporate marketing structure and strategy and look forward to supporting them as they grow. 

During the visit, I was joined by my colleague Dr. Constanze Schelhorn, Head of Indexing, who provided training on indexing. This training was greatly appreciated by the local staff.

Meeting with Prof. Dr. Manoj Gupta

Lastly, we had the privilege of meeting Prof. Dr. Manoj Gupta, Editor-in-Chief (EiC) of Technologies since 2016 and Section EiC of Metals.

Prof. Gupta is an active decision-maker for the journal and a great brand ambassador for MDPI.

Prof. Gupta has helped sustainably scale Technologies, which now has a 4.2 Impact Factor and a 6.7 CiteScore, ranking Q1 in the JCR category of Engineering and Q1 in the CiteScore category of Computer Science.

During our meeting, we discussed strategies for Institutional Open Access Partnership agreements and ways to promote MDPI journals in Singapore.

PS. During the visit, we also had the chance to participate in Lo Hei, also known as Yee Sang or the “prosperity toss.” This is a raw fish salad traditionally enjoyed during Chinese New Year and is particularly popular among Chinese communities in Singapore, Malaysia, and Indonesia. Everyone gathers around the table as the ingredients are added one by one, and then the salad is mixed together. It was a fun experience to take part in this New Year tradition!

 

Coming Together for Science

JAMS – Journal & Article Management System

I am excited to announce the official relaunch of JAMS (Journal & Article Management System), one of MDPI’s key initiatives to support academic publishers worldwide.

With this relaunch, JAMS now offers new pricing models and flexible solutions for small-scale journals, commercial publishers, and university presses. We have also redesigned the JAMS website to enhance the user experience.

“JAMS is a testament to our commitment to simplifying the publishing process”

Explore the new website here: jams.pub

It’s also great to see the JAMS team expanding our presence at conferences and on social media to engage more effectively with the academic community.

Recently, Facundo Santomé (Senior Marketing Manager) and Alex Ramos (Senior Marketing Specialist) represented JAMS at the APE 2025 conference in Berlin, highlighting how our platform empowers small and independent publishers to streamline and scale their journal management.

JAMS was built to change that by adapting to the unique requirements of each publisher.

At MDPI, we continually invest in our growth – not only by expanding our operations and staff but also by developing innovative products that serve the academic and publishing community at large. JAMS, with its comprehensive suite of journal management tools, is a testament to our commitment to simplifying the publishing process for our partners.

Imagine a submission system that frees up your time for strategy, innovation, and impactful publishing.

Under the leadership of Silvano Bonfatti (Product Manager, MDPI), the JAMS team has conducted in-depth market research to understand the challenges publishers face: endless administrative tasks, inefficient workflows, and systems that don’t always meet their needs.

If you believe JAMS could benefit any of your network contacts, please share our website. Contact the JAMS team. They are always ready to assist with your publishing needs.

What Sets JAMS Apart?

  • Scalability – Whether you're a niche journal or managing thousands of submissions, JAMS grows with you.
  • End-to-End Workflow – From submission to peer review and final publication, everything is in one place.
  • Automation That Works for You – Say goodbye to chasing reviewers and formatting issues, so that you can focus on quality instead.
  • Built by Publishers, for Publishers – JAMS is backed by MDPI’s expertise; we know exactly what it takes to run a journal smoothly.
  • Flexible & Fair Pricing – Supporting journals of all sizes, with special rates for non-profits and publishers in the Global South.

Partners Who Already Trust JAMS

If you believe JAMS could benefit any of your network contacts, please share our website. Contact the JAMS team. They are always ready to assist with your publishing needs.

Closing Thoughts

Visit to MDPI's Bangkok office

To conclude my APAC trip, I had the pleasure of visiting our Bangkok office from 22 to 24 January. The office has grown significantly, closing 2024 with a total of 445 colleagues across various departments, including Editorial, Production, Conference, Training, Journal Relationship Specialists (JRS), Managing Editors, and supporting teams in HR, Admin, IT, and Finance.

I would like to praise our Bangkok management team for their excellent work in supporting our growth and creating a positive work environment. Our colleagues here are humble, talented, hardworking, and appreciative of MDPI’s mission.

Thailand was among MDPI’s top 30 markets in 2024 for total publications. With our office in Bangkok, we have an opportunity to further promote open access while supporting local researchers and institutions. This includes open access discounts, author training sessions, conference sponsorships, and other initiatives. We currently have 25 Editorial Board Members (EBMs) from Thailand and will work on expanding this network.

Engaging with Group Leads

“Group leads play an important role in creating a safe, positive environment”

During my visit, I met with our group leads to highlight their crucial role in managing journal performance and mentoring new employees, especially given our increased hiring targets. Many new hires are early in their careers and require training, development, and support. Group leads play an important role in creating a safe, positive environment that fosters professional growth while maintaining MDPI’s reputation for service quality.

To wrap up the session, I added a personal touch by holding the door and giving everyone high-fives – a small gesture to show appreciation, boost morale, and strengthen team spirit. It’s important for our colleagues to feel seen, heard, and valued.

University Visit: King Mongkut’s University of Technology North Bangkok (KMUTNB)

We also visited King Mongkut’s University of Technology North Bangkok (KMUTNB) to explore collaboration opportunities.

Our discussions focused on: Institutional Open Access Partnership (IOAP), Author training sessions, Conference sponsorships, Student employment initiatives, and more.

This visit reinforced the importance of building strong relationships with local universities, ensuring we continue to support and engage with the academic community in Thailand.

“My time in Bangkok was productive and inspiring”

My time in Bangkok was productive and inspiring. The senior team has done a great job in growing the office and creating a supportive, high-performing environment. I look forward to seeing continued success from our colleagues in Thailand.

Stefan Tochev
Chief Executive Officer
MDPI AG

4 February 2025
World Cancer Day 2025—United in Every Journey


Cancer impacts millions of lives worldwide, yet each person’s journey with the disease is uniquely their own. World Cancer Day reminds us that while the disease impacts individuals differently, our shared strength, innovation, and focus on holistic care bring us closer to a future where cancer no longer dictates lives. Every experience, challenge, and success story contribute to the broader fight against cancer, demonstrating the resilience and hope that unite us all. As we continue to make strides through innovative research, treatment advancements, and global collaboration, it is essential to recognize both the diversity of stories and our common goal of overcoming cancer together.

In observance of this day, we invite you to explore the following resources that delve into the field of cancer and the cutting-edge advancements shaping its care. By prioritizing people-centered treatment where patients’ voices and needs guide care, we can ensure personalized attention for all. It is our hope to foster a deeper understanding of the impact of cancer and encourage meaningful action to support patients, caregivers, and researchers in their pursuit of a world free from cancer’s hold. Together, we can inspire action and work toward a cancer-free future.

Biology & Life Sciences

Medicine & Pharmacology

Chemistry & Material Sciences

Public Health & Healthcare

Engineering

Society

Rare Variants of Dermatofibrosarcoma Protuberans: Clinical, Histologic, and Molecular Features and Diagnostic Pitfalls
by Celestine M. Trinidad, Sintawat Wangsiricharoen, Victor G. Prieto and Phyu P. Aung
Dermatopathology 2023, 10(1), 54–62; https://doi.org/10.3390/dermatopathology10010008

Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective
by Adarsh Kumar, Ankit Kumar Singh, Harshwardhan Singh, Veena Vijayan, Deepak Kumar, Jashwanth Naik, Suresh Thareja, Jagat Pal Yadav, Prateek Pathak, Maria Grishina et al.
Pharmaceuticals 2023, 16(2), 299; https://doi.org/10.3390/ph16020299

Artificial Intelligence in Brain Tumor Imaging: A Step toward Personalized Medicine
by Maurizio Cè, Giovanni Irmici, Chiara Foschini, Giulia Maria Danesini, Lydia Viviana Falsitta, Maria Lina Serio, Andrea Fontana, Carlo Martinenghi, Giancarlo Oliva and Michaela Cellina
Curr. Oncol. 2023, 30(3), 2673–2701; https://doi.org/10.3390/curroncol30030203

Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook
by Onyinyechi Obidiro, Gantumur Battogtokh and Emmanuel O. Akala
Pharmaceutics 2023, 15(7), 1796; https://doi.org/10.3390/pharmaceutics15071796

Biomarkers in Breast Cancer: An Old Story with a New End
by Lyvia Neves Rebello Alves, Débora Dummer Meira, Luiza Poppe Merigueti, Matheus Correia Casotti, Diego do Prado Ventorim, Jucimara Ferreira Figueiredo Almeida, Valdemir Pereira de Sousa, Marllon Cindra Sant’Ana, Rahna Gonçalves Coutinho da Cruz, Luana Santos Louro et al.
Genes 2023, 14(7), 1364; https://doi.org/10.3390/genes14071364

Could Microbiome Be the Common Co-Denominator between Type 2 Diabetes and Pancreatic Cancer?
by Marin Golčić and Andrej Belančić
Diabetology 2023, 4(4), 553–559; https://doi.org/10.3390/diabetology4040049

Targeting Solute Carrier Transporters (SLCs) as a Therapeutic Target in Different Cancers
by Ravi Bharadwaj, Swati Jaiswal, Erandi E. Velarde de la Cruz and Ritesh P. Thakare
Diseases 2024, 12(3), 63; https://doi.org/10.3390/diseases12030063

Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer
by Dimitrios Stefanoudakis, Maximos Frountzas, Dimitrios Schizas, Nikolaos V. Michalopoulos, Alexandra Drakaki and Konstantinos G. Toutouzas
Curr. Issues Mol. Biol. 2024, 46(4), 2827–2844; https://doi.org/10.3390/cimb46040177

Metformin: From Diabetes to Cancer—Unveiling Molecular Mechanisms and Therapeutic Strategies
by Emilia Amengual-Cladera, Pere Miquel Morla-Barcelo, Andrea Morán-Costoya, Jorge Sastre-Serra, Daniel Gabriel Pons, Adamo Valle, Pilar Roca and Mercedes Nadal-Serrano
Biology 2024, 13(5), 302; https://doi.org/10.3390/biology13050302

Immune Checkpoint Inhibitors: Fundamental Mechanisms, Current Status and Future Directions
by Abdullah Younis and John Gribben
Immuno 2024, 4(3), 186–210; https://doi.org/10.3390/immuno4030013

Breast Cancer Screening among African Immigrants in the United States: An Integrative Review of Barriers, Facilitators, and Interventions
by Julian I. Rauch, Joseph Daniels, Alyssa Robillard and Rodney P. Joseph
Int. J. Environ. Res. Public Health 2024, 21(8), 1004; https://doi.org/10.3390/ijerph21081004

Predicting Leukoplakia and Oral Squamous Cell Carcinoma Using Interpretable Machine Learning: A Retrospective Analysis
by Salem Shamsul Alam, Saif Ahmed, Taseef Hasan Farook and James Dudley
Oral 2024, 4(3), 386–404; https://doi.org/10.3390/oral4030032

Comprehensive Treatment of Rectal Cancer

Mental Health and Nursing Care of Individuals with Cancer and Their Families—2nd Edition

New Advances in Community-Based Approaches to Cancer Prevention Epidemiology

Cancer Immunotherapy and the PD-1/PD-L1 Checkpoint Pathway

Novel, Low Cost Technologies for Cancer Diagnostics and Therapeutics

Metabolic Reprogramming in Cancer: New Frontiers for Therapeutic Intervention

Pulmonary Fibrosis and Lung Cancer: Pathophysiology and Novel Therapeutic Approaches

 

27 January 2025
Acknowledgment to the Reviewers of Diseases in 2024


The editorial team at Diseases extends our heartfelt thanks to the dedicated reviewers whose expertise and commitment have been key to the journal's success in 2024. Last year, Diseases received 1879 review reports from 1246 reviewers representing 79 countries and regions worldwide.

To recognize the invaluable time, effort, and attention to detail that each reviewer dedicates, Diseases expresses its sincere gratitude through an annual acknowledgment of reviewers.

We are honored to recognize the reviewers who allowed us to publish their names each year. The names of these reviewers are listed below in alphabetical order by first name:

Astrida Velena Kielan Mcalinden
Afshan Masood Kijin Kim
Alejandra García-Gasca Konda Mani Saravanan
Alejandro Vega-Muñoz Konstantinos Efthymakis
Aleksandra Klisic Konstantinos Giakoumidakis
Alessandro Di Rienzo Koyeli Girigoswami
Alessia Verduri Krzysztof Korzeniewski
Alicia Irene Arechavala Kuldeep Gupta
Alireza Fakhriravari Kuo-Hui Su
Alireza Mohammad Karim Laurentiu M. Pop
Amirmohammad Khalaji Lidija Savić
Amit Goel Liliang Li
Ana Andabak Rogulj Lorenzo Malatino
Ana Hećimović Luca Giannella
Anastazia Kei Luca Giacomelli
Andrea Sonaglioni Lucia Ansani
Andreas Anestis Lukasz Szarpak
Andreas Müssigbrodt Lukasz Dobrek
Andreu Comas-Garcia Lyudmila Pivina
Andrew Jin Maciej Przybyłek
Angélica Saraí Jiménez-Osorio Maged Tharwat Elghannam
Angeliki Mavroidi Mahboob Alam
Angelos K. Sikalidis Makoto Endo
Anja Diem Marat Ezhov
Anna Alekseevna Skuredina Marc Beltrà
Anne Kasus-Jacobi Marcel Henrique Marcondes Sari
Anthony Fehr Marco Fiore
Anthony J. Sadler Marcus Krüger
Anton R. Kiselev Margarita Ivanova
Antonio Gidaro María Guadalupe Frías-De-León
Anuj Kumar Maria Kantzanou
Ariel Teles Maria Trovato
Arkalgud Ramaprasad Marino Paroli
Athanassios Tselebis Mario Diplomatico
Baihai Jiao Martine Wallon
Balakumar Chandrasekaran Marzena Jezewska-Zychowicz
Beatriz Teresita Martin Marquez Masoud Keikha
Bernardo Vega Crespo Massimo Montisci
Bernice N. Harris Mathieu David
Bill Primack Matteo Conti
Bin Du Matteo Riccò
Bojana B. Vidović Maximilian Deußing
Boleslaw Tomasz Karwowski Meng-Yao Li
Calin Cainap Michael Eisenhut
Carlos O'Connor-Reina Michał Zarobkiewicz
Carlos Trenado Mieszko Wieckiewicz
Catharina Sagita Moniaga Miguel A. Castro Villamor
Cesar Augusto Roque-Borda Mihai Capilna
Cesar Iván Avilés González Mihalj Poŝa
Chandrabose Selvaraj Milica Aćimović
Charikleia Stefanaki Mirjana Jerkic
Christian Wunder Mirza Pojskic
Christopher Kobierzycki Mohamed Rahouma
Claudiu N. Lungu Mohamed Abuzaid
Consolato Sergi Mohammadreza Shalbafan
Craig Horswill Muhammad Asif Zahoor
Cristian Mornos Myung Goo Lee
Cristina Capatina Narayanaswamy Venketasubramanian
Cyril Fersing Narsimha Mamidi
Daniela Braconi Natale Calomino
Daniele Ugo Tari Natale Musso
Danielle Greenberg Natalia Kamanina
Danijela Budimir Mršić Neeraj Kumar Chauhan
David A. Schwartz Negrut Nicoleta
Dee Wu Nenad Pandak
Delia Lidia Salaru Neus Baena
Demetrios Arvanitis Nicola Magnavita
Derar H. Abdel-Qader Nicola Nante
Dhruvesh Patel Nitin Sampat Kamble
Dia C. Beachboard Nompumelelo Mkhwanazi
Dimitris Tatsis Omid Mirmosayyeb
Dimosthenis Lykouras Omid Akhavan
Dirk W. Lachenmeier Ozgur Karcioglu
Doha Mohamed Panagiotis Savvoulidis
Dominika Guzek Paola Di Carlo
Dorota Formanowicz Paolo Monardo
Ebubekir Daglilar Paolo Landa
Edgar Flores-Soto Patrícia C. Pires
Eduardo Yoshio Nakano Patrick Martin
Eleuterio A. Sánchez-Romero Paweł Glibowski
Elias Kouroumalis Paweł Krzyżek
Elisabetta Tozzi Pedro Infante-Cossio
Emilia Migliano Peter Michael Baptista Jardin
Emiliano Tesoro-Cruz Peter Timmins
Emilio Bucio Petri Böckerman
Emmanouil Ioannis Kapetanakis Pietro Pugliatti
Erica Diani Primrose Freestone
Evangelos Liatsikos Puya Dehgani-Mobaraki
Evgeny N. Imyanitov Qingsen Shang
Fabio Fabbian Rafał Watrowski
Fabrizio Guerra Raghunadharao Digumarti
Farid Ahmed Rana A. Youness
Federica Fogacci Ravendra P. Chauhan
Federico Giorgi Renata Ciccarelli
Federico Marchesi Renata Heisler Neves
Fernando Ferrero Ren-Hau Li
Fernando P. Monroy Reza Nedaeinia
Flavia Leao Barbosa Richard F. Riedel
Flavia Mori Sarti Richard Honeywell
Flor H. Pujol Rishi Jaiswal
Flora De Conto Ritthideach Yorsaeng
Flora N. Balieva Robert Eibl
Francesco Massoni Robert Kleszcz
Francisco Epelde Roberta Di Pietro
Fumio Otsuka Roberto Castiglione
Fushan Tang Roberto Giovanni Carbone
Gang Li Roberto Scarpioni
George Koulaouzidis Roehe Michel Roehe
George Grant Ronit Vogt Sionov
Georgiana Bianca Constantin Roxana Liana Lucaciu
Gerard Goh Sagar Sudam Thorat
Ghulam Jilany Khan Sagarika Biswas
Gianluca Rizzo Said El-Ashker
Gilberto Gonzalez-Parra Salvatore Pezzino
Giovanni La Penna Sandeep Kumar Mishra
Giuliano Tocci Sandro Jose Ribeiro Bonatto
Giuseppe Di Martino Santiago Pedro Aubourg Martínez
Giuseppina Rea Satheesha B. Nayak
Godfrey Mutashambara Rwegerera Satoru Munakata
Gudrun Elisabeth Koehl Seamus O'Reilly
Guillermo Alberto Keller Semer Maksoud
Gulali Aktas Sergei Boichuk
Gustavo Fernandes Sergey Sedykh
Halim Işsever Seyed Ahmad Naseri Alavi
Halina Tkaczenko Shaher Hamaideh
Hamid Tebyaniyan Shalimar
Hamidreza Karimi-Sari Shaonong Dang
Harald Krentel Shehwaz Anwar
Henry Atkinson Shek Man Chim
Henry Lukaski Sherien Eldaly
Hitesh Chopra Shweta Tripathi
Hitoshi Tonomura Silvia Hofer
Hongmei Dong Simone Brogi
Hosoon Choi Singh Kumar Avishek
Hussam Ali Siyong Kim
Hwei Jene Ng Somya Agrawal
Ibrahim Gosadi Stefano Filippi
Ignazio Gaspare Vetrano Stefano Francesco Crinò
Ina Sevic Stephanie Dauth
Ioannis Ventoulis Subbarao V. Madhunapantula
Irena Ilic Sueli Fumie Yamada-Ogatta
Irina Vlasova-St. Louis Sulev Koks
Irma González-Curiel Sushant Covaris
Ivanildo Sousa Syed Nabil
Ivo Lopes Tadahisa Sugiura
James Patrick O'Connor Tajamul Hussain
Jacek Cholewicki Takemichi Fukasawa
Jacek Piątek Tania Colasanti
Jader De Oliveira Tarek M.A. Abdel-Fatah
Jaishree Raman Terenzio Cosio
Javier Martínez Torres Tetyana Chumachenko
Jean-Marie Exbrayat Tomislav Tosti
Jeni Prosperi Torbjörn Ledin
Jenna E. Coalson Ulf Schött
Jeremy Marks Ursula Panzner
Jia-Feng Chang Vaitsa Giannouli
Jialing Lin Vajir Malek
Jihua Guo Valentina Lancellotta
Jiří Remr Valerio Leoni
Joan-Lluis Vives Corrons Vance Nielsen
Joanna Dzido Vasiliki Karava
João Paulo Saraiva Santos Vasudevan Gowthaman
John K. Triantafillidis Víctor José González Ramallo
John Lalith Charles Richard Victoria Bunik
John P.A. Lusingu Vijay Patel
Jonathan Karp Vincent Ho
Jong-Hwa Jang Wei Boon Yap
Jorge Feito Wei-Ting Lin
Jose Martinez-Hernandez Wilhelm Peter Mistiaen
José Antonio De Paz Wing Shing Ho
José Artur Bogo Chies Wioletta Rozpędek-Kamińska
Jose-Luis Pérez-Castrillón Wissem Mnif
Josip Andelo Borovac Wladimir Bocca Vieira de Rezende Pinto
Juan Alberto Castillo-Garit Xian-Zhi Li
Juan Francisco Leon Yanka Dimitrova Karamalakova
Juan de los Toyos Yaoxiang Li
Juandy Jo Yasin Tülüce
Judy Gopal Yi-Qing Yang
Karel Van Den Bosch Yong Jin
Karen Bohmwald Yongbo Liang
Karolina Akinosoglou Yongsheng Chen
Katarina Sebekova Zehuan Liao
Katsuya Kitamura Zeljko Prijovic
Kay-Dietrich Wagner Zhenbo Xu
Kazuhiko Hashimoto Zhengwei Huang
Keita Kai Zhiwei Yang
Keith Rochfort Zoran Gluvic
Kenneth N. White Zoran Todorovic
Keren Dopelt Zornitsa Gancheva Kamenarska
 Khalid Muhammad

26 January 2025
World Neglected Tropical Diseases Day—30 January 2025


On 31 May 2021, the World Health Assembly (WHA) recognized 30 January as World Neglected Tropical Disease (NTD) Day. This decision formalized 30 January as a day to create better awareness on the devastating impact of NTDs on the poorest populations around the world. The day is also an opportunity to call on everyone to support the growing momentum for the control, elimination and eradication of these diseases.

We would like to recommend some related articles, Special Issues, and journals in the field of medicine & pharmacology as suitable communication platforms for you. We believe that sharing research like this can help raise awareness of NTDs.

   

A Fatal Case of Presumptive Diagnosis of Leptospirosis Involving the Central Nervous System
by Christina Alexopoulou, Athanasia Proklou, Sofia Kokkini, Maria Raissaki, Ioannis Konstantinou and Eumorfia Kondili
Healthcare 2024, 12(5), 568; https://doi.org/10.3390/healthcare12050568

Evaluation of an Artificial Intelligence-Based Tool and a Universal Low-Cost Robotized Microscope for the Automated Diagnosis of Malaria
by Carles Rubio Maturana, Allisson Dantas de Oliveira, Francesc Zarzuela, Alejandro Mediavilla, Patricia Martínez-Vallejo, Aroa Silgado, Lidia Goterris, Marc Muixí, Alberto Abelló, Anna Veiga et al.
Int. J. Environ. Res. Public Health 2025, 22(1), 47; https://doi.org/10.3390/ijerph22010047

Chagas Disease in the Non-Endemic Area of Rome, Italy: Ten Years of Experience and a Brief Overview
by Maria Letizia Giancola, Andrea Angheben, Laura Scorzolini, Stefania Carrara, Ada Petrone, Antonella Vulcano, Raffaella Lionetti, Angela Corpolongo, Rosalia Marrone, Francesca Faraglia et al.
Infect. Dis. Rep. 2024, 16(4), 650-663; https://doi.org/10.3390/idr16040050

Uptake and Effectiveness of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine during Pregnancy in Africa: A Scoping Review
by Gifty Osei Berchie, Patience Fakornam Doe, Theodora Dedo Azu, Joyce Agyeiwaa, Gifty Owusu, Christian Makafui Boso, Naomi Kyeremaa Yeboa, Dorcas Frempomaa Agyare, Irene Korkoi Aboh, Bernard Nabe et al.
Diseases 2024, 12(9), 203; https://doi.org/10.3390/diseases12090203

Laparoscopic Management of Multiple Liver, Omental, Mesenteric, Peritoneal, and Round Ligament Hydatid Cysts—A Rare Report of a Case and a Systematic Literature Review
by Alin Mihetiu, Dan Georgian Bratu, Ciprian Tanasescu, Bogdan Ioan Vintilă, Alexandra Sandu, Mariana Sandu, Dragos Serban, Dan Sabau and Adrian Hasegan
J. Pers. Med. 2024, 14(2), 205; https://doi.org/10.3390/jpm14020205

False-Positive Malaria Rapid Diagnostic Test Likely Due to African Tick Bite Fever: A Case Report
by Rahel T. Zewude, Syed Zain Ahmad, Tom Joseph and Andrea K. Boggild
Reports 2024, 7(4), 100; https://doi.org/10.3390/reports7040100

Increasing Risk of Tick-Borne Disease through Growth Stages in Ticks
by Makoto Kondo, Yoshiaki Matsushima, Takehisa Nakanishi, Shohei Iida, Habe Koji and Keiichi Yamanaka
Clin. Pract. 2023, 13(1), 246-250; https://doi.org/10.3390/clinpract13010022

Oral Chagas Disease in Colombia—Confirmed and Suspected Routes of Transmission
by Norman L. Beatty, Catalina Arango-Ferreira, Lídia Gual-Gonzalez, Sara Zuluaga, Melissa S. Nolan and Omar Cantillo-Barraza
Trop. Med. Infect. Dis. 2024, 9(1), 14; https://doi.org/10.3390/tropicalmed9010014

Global Patterns of Trends in Incidence and Mortality of Dengue, 1990–2019: An Analysis Based on the Global Burden of Disease Study
by Irena Ilic and Milena Ilic
Medicina 2024, 60(3), 425; https://doi.org/10.3390/medicina60030425

DengueFog: A Fog Computing-Enabled Weighted Random Forest-Based Smart Health Monitoring System for Automatic Dengue Prediction
by Ashima Kukkar, Yugal Kumar, Jasminder Kaur Sandhu, Manjit Kaur, Tarandeep Singh Walia and Mohammed Amoon
Diagnostics 2024, 14(6), 624; https://doi.org/10.3390/diagnostics14060624

Global Fight against Malaria: Goals and Achievements 1900–2022
by Marc Thellier, Ayawovi Arlene Jessicka Gemegah and Ilhame Tantaoui
J. Clin. Med. 2024, 13(19), 5680; https://doi.org/10.3390/jcm13195680

Oropouche Virus Exposure in Febrile Patients during Chikungunya Virus Introduction in the State of Amapá, Amazon Region, Brazil
by Raquel Curtinhas de Lima, Helver Gonçalves Dias, Thiara Manuele Alves de Souza, Débora Familiar-Macedo, Edcelha D’Athaide Ribeiro, Valmir Corrêa e Corrêa, Alex Pauvolid-Corrêa, Elzinandes Leal de Azeredo and Flávia Barreto dos Santos
Pathogens 2024, 13(6), 469; https://doi.org/10.3390/pathogens13060469

Adenovirus-Mediated Expression of Dengue Virus 2 Envelope Ferritin Nanoparticles Induced Virus-Specific Immune Responses in BALB/c Mice
by M.S.B.W.T.M. Nipuna Sudaraka Tennakoon, Ji-Hoon Ryu, Yong-Sam Jung, Yingjuan Qian and Hyun-Jin Shin
Microbiol. Res. 2024, 15(3), 1913-1923; https://doi.org/10.3390/microbiolres15030128

Evolution of the Quinoline Scaffold for the Treatment of Leishmaniasis: A Structural Perspective
by Carlos F. M.Silva, Diana C. G. A. Pinto, Pedro A. Fernandes and Artur M. S. Silva
Pharmaceuticals 2024, 17(3), 285; https://doi.org/10.3390/ph17030285

Prevalence of Intestinal Parasites, Protozoans and Soil-Transmitted Helminths, in Children from Communities of Northern Argentina after the Interruption of Deworming
by Ernesto Candela, Rubén O. Cimino, Leonardo Sandon, Carla Muñoz-Antoli and María Victoria Periago
Parasitologia 2024, 4(2), 172-183; https://doi.org/10.3390/parasitologia4020015

Global Lipidomics Reveals the Lipid Composition Heterogeneity of Extracellular Vesicles from Drug-Resistant Leishmania
by Sehyeon (Erica) Kim, Ana Victoria Ibarra-Meneses, Christopher Fernandez-Prada and Tao Huan
Metabolites 2024, 14(12), 658; https://doi.org/10.3390/metabo14120658

Special Issue: “Infectious Disease Prevention and Public Health Promotion: Second Edition

Special Issue: “Advances in Molecular Diagnosis in Neglected Tropical Diseases

Special Issue: “One Health and Neglected Zoonotic Diseases

Special Issue: “Dysbiosis and Metabolic Disorders of the Microbiota

26 January 2025
Meet Us at the 55th Annual Meeting of the Japanese Society for Cardiovascular Surgery, 20–22 February 2025, Yamaguchi, Japan


Conference:
The 55th Annual Meeting of the Japanese Society for Cardiovascular Surgery
Date: 20–22 February 2025
Location:
Yamaguchi, Japan

MDPI will be attending the 55th Annual Meeting of the Japanese Society for Cardiovascular Surgery as an exhibitor which will be held from 20 to 22 February 2025. We invite researchers from different fields of study to share their ideas with us.

The 55th Annual Meeting of the Japanese Society for Cardiovascular Surgery will be held in Shimonoseki. The theme of the annual meeting is “Beyond The WAVE! Go on and overcome!”. This meeting theme aims to help surgeons overcome difficulties and challenges during their growth and development. The entire meeting will be split into five areas of coronary artery disease—valvulopathy, aortic disease, congenital malformations, and peripheral vascular disease—each of which has its own Program Committee that has put together the primary sessions. Attending the meeting is important for academic learning at the venue, but exchanging views with other participants, obtaining new information, and engaging in conversations is also extremely meaningful.

The following MDPI journals will be represented at the conference:

If you are planning to attend the above conference, please do not hesitate to visit booth #27 and start a conversation with us. Our delegates look forward to meeting you in person and answering any questions you may have. We warmly encourage researchers from different backgrounds to visit and share their ideas with us.

For more information about the conference, please visit the following website: https://www.congre.co.jp/jscvs2025/en/index.html.

Back to TopTop